Results 201 to 210 of about 39,319 (333)

ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO [PDF]

, 2016
F. Carlos, M. Zurita Herrera, Aníbal Salazar, Andrew J. Aguirre, L González-Michaca   +4 more
openalex   +1 more source

Inhibition of head and neck squamous cell carcinoma by Bruton's tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells. [PDF]

Cancer Immunol Immunother
Bopp AR, Lamenza FF, Upadhaya P, Ryan NM, Kazmierowicz N, Jordanides PP, Siddiqui A, Pracha SH, Roth P, Iwenofu OH, Oghumu S.   +10 more
europepmc   +1 more source

CLL bei Älteren: Ibrutinib in der Erstlinie bald schon Standard? [PDF]

, 2016
Barbara Kreutzkamp
openalex   +1 more source

Ibrutinib

Reactions Weekly, 2021
openaire   +1 more source

Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma [PDF]

, 2016
Simone Critchlow, Dawn Lee, Alizée Latour, Mark Wildgust, Jeffrey L. Goldberg, Simon Rule, M Wang   +6 more
openalex   +1 more source

A Comparative Analysis of Cardiovascular Events Associated With Acalabrutinib Versus Ibrutinib in Chronic Lymphocytic Leukemia: Insights From a Global Federated Network. [PDF]

Pharmacol Res Perspect
Majrashi A, Gue YX, Shantsila A, Williams S, Smith CT, Lip GYH, Pettitt AR.   +6 more
europepmc   +1 more source

Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenstrom macroglobulinemia

, 2015
Martin F. M. de Rooij, Annemieke Kuil, Willem Kraan, Marie José Kersten, Steven P. Treon, Steven T. Pals, Marcel Spaargaren   +6 more
openalex   +1 more source

IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHARMACOKINETIC RESULTS FROM THE HELIOS TRIAL [PDF]

, 2017
Paula Cramer, Fatih Demırkan, Graeme Fraser, Alexander Pristupa, Nancy L. Bartlett, M.S. Dilhuydy, Javier Loscertales, Abraham Avigdor, Simon Rule, Olga Samoilova, André Goy, Siddhartha Ganguly, Italo Poggesi, Silvia Maria Lavezzi, Giuseppe De Nicolao, Jan de Jong, Martine Neyens, Mariya Salman, Angela Howes, Michelle Mahler   +19 more
openalex   +1 more source

Ibrutinib therapy for lymphoplasmacytic lymphoma [PDF]

American Journal of Hematology, 2017
Margaret J. Helber, Jeremiah E. Moore, AnnaLynn M. Williams, Philip J. Meacham, Paul G. Rothberg, Clive S. Zent   +5 more
openaire   +3 more sources

Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia: Adverse Event Incidence, Management, and Outcomes in a Canadian Real-World Setting. [PDF]

Curr Oncol
Othman I, Moossavi SZM, Bayati S, Chang YS, Sanjoy S, Grzyb K, Sy E, Cropper K, Kassir S, Sabry W.   +9 more
europepmc   +1 more source